Related Experiment Videos
The heart in scleroderma: noninvasive assessment
Clinical Cardiology
|June 1, 1982
Summary
Isometric handgrip exercise can reveal subclinical left ventricular fibrosis in scleroderma patients, even with normal cardiovascular exams. This noninvasive method, supported by immunohistology, detects fibrosis indicated by abnormal heart rate and timing responses.
Area of Science:
- Cardiovascular Medicine
- Rheumatology
- Pathology
Background:
- Scleroderma frequently involves myocardial fibrosis, detectable postmortem in up to 80% of patients.
- Many scleroderma patients exhibit normal cardiovascular examinations, masking underlying cardiac issues.
- Subclinical myocardial fibrosis contributes to cardiac dysfunction in scleroderma.
Purpose of the Study:
- To investigate isometric handgrip exercise as a noninvasive method for detecting subclinical left ventricular fibrosis in scleroderma.
- To correlate exercise-induced cardiovascular responses with immunohistological findings of myocardial fibrosis.
Main Methods:
- Compared 15 scleroderma patients (AHA criteria) with 15 age/sex-matched controls using isometric handgrip exercise.
- Assessed heart rate response, systolic and diastolic time intervals (pre-ejection period/ejection time ratio, isovolumic relaxation time).
- Performed immunohistological staining for collagen types I-V in cardiac muscle biopsies.
Main Results:
- Scleroderma patients showed a depressed heart rate response (p<0.05) and abnormal systolic/diastolic time intervals.
- A decreased pre-ejection period/ejection time ratio (p<0.05) and prolonged isovolumic relaxation time were observed in scleroderma patients.
- Immunohistology revealed excess collagen types I, III, and IV in cardiac muscle, supporting fibrosis.
Conclusions:
- Isometric handgrip exercise can unmask subclinical left ventricular fibrosis in scleroderma.
- Abnormal cardiovascular responses during isometric exercise indicate impaired left ventricular contractility and stiffness.
- Immunopathological findings confirm the presence of myocardial fibrosis in patients without overt cardiac disease.